BudCapital

Specialty drug manufacturer - 3rd round of put buying

Short
NYSE:VRX   None
1
$VRX estimated report date is feb 22nd. Options market is pricing in a 15% move. Implied volatility is fairly high but this is the 3rd round of put buying I have noticed in the last month. Watching for a strong volume breakdown.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.